Literature DB >> 172850

Pyruvate dehydrogenase phosphatase deficiency: a cause of congenital chronic lactic acidosis in infancy.

B H Robinson, W G Sherwood.   

Abstract

A male child presented on the first day of life with metabolic acidosis with elevated blood lactate (15 mM), pyruvate (0.4 mM), and free fatty acid (1.3 mM) levels and a blood pH of 7.16. The severity of the acidosis was diminished by intravenous administration of glucose in large doses and by bicarbonate. On two occasions, when the acidosis was particularly severe, peritoneal dialysis using an acetate buffer was required. Restriction of the dietary intake of saturated fatty acids or treatment with nicotinic acid also appeared to diminish the severity of acidosis. No improvement was achieved by the administration of thiamine or biotin. Tissues taken at postmortem showed normal activity of gluconeogenic enzymes and pyruvate dehydrogenase. The activity of pyruvate dehydrogenase in tissue homogenates preincubated with ATP was reduced by 60-75% both in liver of the patient and of the controls because of the inactivation of the enzyme by pyruvate dehydrogenase kinase. Addition of Ca++ and Mg++ to the inactivated enzyme caused a prompt return of the activity to normal in controls but not in the patient. This defect, which was apparent in muscle and liver but not in brain, we attribute to a markedly reduced activity of pyruvate dehydrogenase phosphatase in the patient.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 172850     DOI: 10.1203/00006450-197512000-00015

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  18 in total

1.  Histochemical technique for the demonstration of pyruvate kinase activity.

Authors:  A E Meijer; R van den Hoven
Journal:  Histochemistry       Date:  1988

2.  Congenital lactic acidosis due to pyruvate carboxylase deficiency: absence of an inhibitor of TPP-ATP phosphoryl transferase.

Authors:  K Tada; G Takada; K Omura; Y Itokawa
Journal:  Eur J Pediatr       Date:  1978-01-17       Impact factor: 3.183

Review 3.  Disorders of the pyruvate dehydrogenase complex.

Authors:  D Stansbie; S J Wallace; C Marsac
Journal:  J Inherit Metab Dis       Date:  1986       Impact factor: 4.982

4.  Mitochondrial myopathies: disorders of the respiratory chain and oxidative phosphorylation.

Authors:  J B Clark; D J Hayes; J A Morgan-Hughes; E Byrne
Journal:  J Inherit Metab Dis       Date:  1984       Impact factor: 4.982

5.  Lactic acidaemia.

Authors:  B H Robinson; W G Sherwood
Journal:  J Inherit Metab Dis       Date:  1984       Impact factor: 4.982

6.  Organic acids in urine of patients with congenital lactic acidoses: an aid to differential diagnosis.

Authors:  R A Chalmers
Journal:  J Inherit Metab Dis       Date:  1984       Impact factor: 4.982

7.  Deficiency of the iron-sulfur clusters of mitochondrial reduced nicotinamide-adenine dinucleotide-ubiquinone oxidoreductase (complex I) in an infant with congenital lactic acidosis.

Authors:  R W Moreadith; M L Batshaw; T Ohnishi; D Kerr; B Knox; D Jackson; R Hruban; J Olson; B Reynafarje; A L Lehninger
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

8.  Pyruvate dehydrogenase phosphatase 1 (PDP1) null mutation produces a lethal infantile phenotype.

Authors:  J M Cameron; M Maj; V Levandovskiy; C P Barnett; S Blaser; N Mackay; J Raiman; A Feigenbaum; A Schulze; B H Robinson
Journal:  Hum Genet       Date:  2009-01-30       Impact factor: 4.132

9.  Pyruvate-dehydrogenase complex in ataxic patients: enzyme deficiency in ataxic encephalopathy plus lactic acidosis and normal activity in Friedreich ataxia.

Authors:  G Uziel; E Bottacchi; G Moschen; P Giovanardi-Rossi; G Cardace; S Di Donato
Journal:  Ital J Neurol Sci       Date:  1982-12

10.  Lactic acidosis, neurological deterioration and compromised cellular pyruvate oxidation due to a defect in the reoxidation of cytoplasmically generated NADH.

Authors:  B H Robinson; J Taylor; B Francois; A L Beaudet; D F Peterson
Journal:  Eur J Pediatr       Date:  1983-04       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.